How many insider trades does FilingIQ track for CERO?

FilingIQ tracks 39 Form 4 insider transactions for CERO (CERO THERAPEUTICS HOLDINGS, INC.), covering filings from Feb 14, 2024 onwards. 1 of those were filed in the last 90 days.

Are CERO insiders net buyers or net sellers?

Across the full Form 4 history for CERO, 0 transactions (0%) were open-market purchases and 8 (21%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CERO insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CERO in?

CERO THERAPEUTICS HOLDINGS, INC. (CERO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $696388.

CERO insider trading

OTC Markets OTCQB Healthcare

CERO THERAPEUTICS HOLDINGS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 21%

Market cap

$696388

About CERO THERAPEUTICS HOLDINGS, INC.

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.

Company website: www.cero.bio

CERO insider activity at a glance

FilingIQ has scored 39 insider transactions for CERO since Feb 14, 2024. The most recent filing in our index is dated Mar 4, 2026.

Across the full history, 0 open-market purchases and 8 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CERO insider trades is 52.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CERO trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for CERO?: FilingIQ tracks 39 Form 4 insider transactions for CERO (CERO THERAPEUTICS HOLDINGS, INC.), covering filings from Feb 14, 2024 onwards. 1 of those were filed in the last 90 days.
Are CERO insiders net buyers or net sellers?: Across the full Form 4 history for CERO, 0 transactions (0%) were open-market purchases and 8 (21%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CERO insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CERO in?: CERO THERAPEUTICS HOLDINGS, INC. (CERO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $696388.

Methodology & sources

Every CERO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.